Vitiligo Treatment Market Projected to Reach US$ 1,944.5 Mn by 2026; Rise in the Research and Development Activities to Boost Growth, says Fortune Business Insights

Key Companies Covered in the Vitiligo Treatment Market Research Report are Incyte Corporation, Astellas Pharma Inc., Bausch Health Companies Inc., Baxter International Inc., Pfizer Inc., STRATA Skin Sciences, Dr. Reddy’s Laboratories Ltd. and other key market players.


Pune, June 08, 2020 (GLOBE NEWSWIRE) -- The global vitiligo treatment market is likely to gain impetus from an ever rising demand for innovative and modern treatment options for vitiligo. According to Fortune Business Insights, titled, “Vitiligo Treatment: Global Market Analysis, Insights and Forecast, 2019-2026,” the global vitiligo treatment market was valued at US$ 1,243.8 Mn in 2018. The market is projected to reach US$ 1,944.5 Mn by 2026, exhibiting a CAGR of 5.8% in the forecast period.



Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/vitiligo-treatment-market-100580



In terms of treatment, the global vitiligo treatment market is grouped into topical treatment, surgical procedures, light therapy, and others. Amongst these, the topical treatment segment had held majority of the vitiligo treatment market share. This is because of the increasing patient pool, need for numerous treatment methods for vitiligo, and an increasing number of research and development activities. However, lack of awareness regarding the available vitiligo treatment and reduction in the diagnosis rate may hamper the vitiligo treatment market growth.



An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

To get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/vitiligo-treatment-market-100580



Increasing Number of Vitiligo Patients to Favor Growth in Asia Pacific

The global vitiligo treatment market is geographically divided into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. Amongst these, in Asia Pacific, India, China, and the other Southeast Asian countries have been witnessing huge patient pools of vitiligo.

This has further resulted in an urgent requirement for effective treatment options available of vitiligo. The markets of Latin America and the Middle East and Africa, on the other hand are expected witness notable grow in the near future. This is because darker skinned individuals who suffer from vitiligo are demanding for modern methods of treatment that would help the condition become less noticeable on them.

In North America, the vitiligo treatment market was valued at US$ 314.1 Mn in 2018. This is because of a rise in the research and development activities and an increasing adoption of vitiligo treatment. Numerous healthcare providers in the U.S., are also implementing advanced technologies in the treatment of vitiligo.

Also, the number of vitiligo affected populace is growing rapidly there. In Europe, an unmet need for advanced treatment options is likely to boost vitiligo treatment market growth. Fortune Business Insights predicts that Asia Pacific will witness a remarkably high CAGR during the forthcoming years. This is likely to occur because of huge patient pool in the region.



Quick Buy -  Vitiligo Treatment Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/100580



Key Players Focus on Effective Medicine Launch to Strengthen Market Position 

Incyte Corporation, a pharmaceutical company, based in the U.S., announced the result of its dose-ranging, randomized, vehicle-controlled, and double-blind Phase 2 study evaluating ruxolitinib cream, an anti-inflammatory, nonsteroidal, and JAK inhibitor therapy in patients with vitiligo between the age group of 18 to 75 years of age.

The results were out after 24 weeks. The study met its primary goal and treated many patients with the help of ruxolitinib cream for 24 weeks. The results were presented at the 24th World Congress of Dermatology in Italy. The positive result supports the potential of ruxolitinib cream in providing novel treatment for chronic autoimmune disease.

Dr. Reddy’s Laboratories Ltd., a multinational pharmaceutical company, headquartered in Hyderabad, announced the launch of Melgain in June 2014. Melgain is a lotion that is considered to be the first peptide-based drug for vitiligo. The lotion is effective and very safe to use for the treatment of vitiligo for children and adults.



List of the Key Companies Operating in the Vitiligo Treatment Market are:

  • Incyte Corporation
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc.
  • Baxter International Inc.
  • Pfizer Inc.
  • STRATA Skin Sciences
  • Dr. Reddy’s Laboratories Ltd.
  • Other players



Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/vitiligo-treatment-market-100580



Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of vitiligo by key countries
    • Pipeline analysis
    • Recent industry developments - mergers & acquisitions
    • Recent developments in R&D
  • Global Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Treatment
      • Topical Treatment
      • Light Therapy
      • Surgical Procedures
      • Others
    • Market Analysis, Insights and Forecast – By Disease Type
      • Nonsegmental Vitiligo
      • Segmental Vitiligo
    • Market Analysis, Insights and Forecast – By End-user
      • Hospitals
      • Aesthetic Clinics
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East & Africa

TOC Continued….!!!


Request for Customization:
https://www.fortunebusinessinsights.com/enquiry/customization/vitiligo-treatment-market-100580


Have a Look at Related Reports:

Anti-Fungal Drugs Market Size, Share & Industry Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Drug Stores, and Others), and Regional Forecast, 2020-2027

Anti-Inflammatory Drugs Market Size, Share & Industry Analysis, By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids), By Application (Autoimmune Inflammatory Diseases (Rheumatoid Arthritis Psoriasis), Respiratory Diseases), By Route of Administration (Oral, Injection, Inhalation, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), and Regional Forecast, 2020-2027

Nebulizer Market Size, Share & COVID-19 Impact Analysis, By Type (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) By Modality (Portable, and Table-top) By End User (Hospitals, Clinics, and Homecare Settings), and Regional Forecast, 2020-2027

Deep Brain Stimulation Devices Market Size, Share & Industry Analysis, By Product Type (Dual Channel Deep Brain stimulators, Single Channel Deep Brain Stimulators), By Application (Parkinson's Disease, Dystonia, Essential Tremor, Others), By End User (Hospitals, Specialty Clinics, Others) and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/vitiligo-treatment-market-9220